The use of botulinum toxin as an adjunct in the treatment of bruxism
DOI:
https://doi.org/10.33448/rsd-v12i6.42200Keywords:
Botulinum Toxins, Type A; Bruxism; Face.Abstract
Bruxism is a disorder characterized by clenching or grinding of teeth, which occurs both during sleep and wakefulness. Stress and emotional factors are considered the main triggers, along with sleep disturbances, medication use and the presence of pain. The diagnosis of bruxism involves anamnesis and clinical analysis, such as pain in the masticatory muscles and temporomandibular joint (TMJ). The main symptoms reported by patients are TMJ pain, difficulty chewing and limited mouth opening. The treatment of bruxism may include the use of myorelaxing plates, which help to reduce teeth clenching and grinding, and the application of botulinum toxin (TXB), which promotes muscle relaxation. However, it is important to highlight that bruxism is a multifactorial disorder and the therapeutic approach must consider all aspects involved. Furthermore, the efficacy and safety of using TXB in the treatment of bruxism are still matters of debate, and more research is needed to support its recommendation. It is essential that professionals act ethically and responsibly, taking into account the physical, psychological and social aspects of the patient, and offering therapeutic alternatives based on robust scientific evidence. The use of TXB as an adjunctive treatment of bruxism in orofacial harmonization (HOF) can be promising, but the critical issues mentioned need to be addressed. Thus, the objective of this article is to carry out, through a narrative review of the literature, the supporting use of TXB type A for the control of bruxism.
References
Akemi, K., & Ziroldo, S. (2017). Tratamento para o bruxismo com toxina botulínica: relato de caso. Revista Clínica de Ortodontia Dental Press, 1(16):70-77.
Bahils, A., Rodrigues, N. L., & Ferrari, E. (1999). Bruxismo. Revista Odonto Ciência, 27:7-20.
Barbosa, C. M. R., Arana, A. R. S., & Bourreau, M. L. S. (2000). Botox. Bruxismo. Iniciação Científica Cesumar, 2(1):23-25.
Bulanda, S., Ilczuk-Rypuła, D., Nitecka-Buchta, A., Nowak, Z., Baron, S., & Postek-Stefańska, L. (2021). Sleep Bruxism in Children: Etiology, Diagnosis, and Treatment-A Literature Review. International journal of environmental research and public health, 18(18), 9544.
Colhado, O. C. G., Boeing, M., Ortega, L. B. (2009). Toxina Botulínica no Tratamento da Dor. Revista Brasileira de Anestesiologia, 59(3):366-381.
Cowie, R. R. (2004). The clinical use of night guards: occlusal objectives. Dent Today. 23(9):112-115.
Donini, E. D. et al. (2013). Uso da toxina botulínica tipo A em pacientes com bruxismo reabilitados com prótese do tipo protocolo em carga imediata. Jornal Ilapeo, 7(1):42.
Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(4), e416–e424.
Gaida, P. S. (2004). Bruxismo um Desafio para a Odontologia. Curso de Especialização em Prótese Dentária, Departamento de Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Florianópolis.
Gama, E., Andrade, A. O., & Campos, R. M. (2013). Bruxismo: uma revisão da literatura. Ciência Atual, 1(1):16-22.
Glaros, A. G., & Rao, S., M. (1977). Effects of bruxism: A review of the literature. The Journal Of Prosthetic Dentistry, 38(2):149-157.
Kane, M., & Sattler, G. (2016). Guia Ilustrado para Infiltrações Estéticas com Toxina Botulínica: base, localização, utilidades. DiLivros.
Koyano, K., Tsukiyama, Y., Ichiki, R., & Kuwata, T. (2008). Assessment of bruxism in the clinic. Journal of oral rehabilitation, 35(7), 495–508.
Kuang, B., Li, D., Lobbezoo, F., de Vries, R., Hilgevoord, A., de Vries, N., Huynh, N., Lavigne, G., & Aarab, G. (2022). Associations between sleep bruxism and other sleep-related disorders in adults: a systematic review. Sleep medicine, 89, 31–47.
Lobbezoo, F., Ahlberg, J., Glaros, A. G., Kato, T., Koyano, K., Lavigne, G. J., de Leeuw, R., Manfredini, D., Svensson, P., & Winocur, E. (2013). Bruxism defined and graded: an international consensus. Journal of oral rehabilitation, 40(1), 2–4.
Macedo CR, Silva AB, Machado MA, Saconato H, Prado GF. Occlusal splints for treating sleep bruxism (tooth grinding). Cochrane Database Syst Rev. 2007;2007(4):CD005514.
Nadler, S. C. (1957). Bruxism, a classifi cation: critical review. J Am Dent Assoc, 54:615-622.
Okajima, M. (2013). Toxina botulínica: da terapia a estética. Ident.
Okeson, J. P. (1992). Fundamentos de oclusão e desordens temporomandibulares. 2.ed.: Artes Médicas.
Pedron, I. G. (2014). Aplicação da toxina botulínica associada à clínica integrada no tratamento do sorriso gengival. Revista do Instituto de Ciências da Saúde, 32(4):365-369.
Peters, A. R., & Gross, S.G. (1995). Clinical management of temporomandibular disorders and orofacial pain. Quintessence Publishing.
Portella, L. V., et al. (2004). Os efeitos da toxina botulínica no tratamento da espasticidade: uma revisão da literatura. Revista Fisioterapia e Pesquisa, 47-55.
Pretel H., & Cação, I. (2016). Harmonização orofacial: toxina botulínica, preenchedores orofaciais e fototerapia. São José dos Pinhais: Plena.
Primo, P. P., Miura, C. S. N., & Boleta-Ceranto, D. C. F. (2009). Considerações fisiopatológicas sobre o bruxismo. Revista Ciência Saúde, 13(3):263-266.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).
Seraidarian, P. I., Assunção, Z. L. V., Jacob, M. F. (2001). Bruxismo: uma atualização dos conceitos, etiologia, prevalência e gerenciamento. JBA, 1(4):290-295.
Serrano, P. O. (2006). Efeito do desgaste dental causado por bruxismo sobre a distância interoclusal. FOP.
Sposito, M. M. M., & Teixeira, S. A. F. (2014). Toxina botulínica tipo a para bruxismo: análise sistemática. Acta Fisiátrica, 21(4):201-204.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Thalita Macedo Marques; Roberto Teruo Suguihara; Daniella Pilon Muknicka
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
